Document is current
Any future updates will be listed below
-
Authors
Herion, Isabelle
Steinbart, David https://orcid.org/0000-0002-6952-430X
Dimova, Desislava
Holtkamp, Martin https://orcid.org/0000-0003-2258-1670
-
Funding
Funding for this research was provided by:
von Bodelschwingh Foundation
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 7 March 2026
Revised: 23 March 2026
Accepted: 25 March 2026
First Online: 7 April 2026
Declarations
:
: Martin Holtkamp received payments as speaker from Angelini, Bial, Danone, Desitin, Eisai, Jazz, Neuraxpharm, and UCB within the last 3 years, all are unrelated to the current study. The other authors report no competing interests.
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. This study was carried out in accordance with the World Medical Association Declaration of Helsinki and it was approved by the Institutional Review Board of the Charité—Universitätsmedizin Berlin (EA2/306/20).
